Results 41 to 50 of about 134,211 (194)
JGH Open, 2020 Introduction Gastric varices (GVs) occur in 10–30% of liver cirrhotic patients, with a mortality rate of up to 45%. Rupture of isolated GVs (IGVs) is less prevalent but often results in more severe hemorrhage and a higher risk of mortality than rupture ...
Cosmas Rinaldi A Lesmana +10 more
doaj +1 more source
The Pan African Medical Journal, 2021 INTRODUCTION: Currently, the non-steroid anti-inflammatory drugs constitute a veritable object of auto medication throughout the world. The goal of this study was to evaluate the endoscopic and clinical aspects of gastro-duodenal ulcer secondary to ...
Oumar Traoré +5 more
doaj +1 more source
Ligation of Esophageal Varices [PDF]
, 2013 Esophageal varices are present in majority of the patients with hepatic cirrhosis at the time of diagnosis, especially in those with advanced liver disease.
Shou-jiang Tang, Tang, Shou-jiang
core +1 more source
International Journal of Hepatology, Volume 2026, Issue 1, 2026.Background There is evolving evidence regarding whether pre‐emptive transjugular intrahepatic portosystemic shunt (p‐TIPS) improves outcomes in patients with acute variceal bleeding. This meta‐analysis is aimed at evaluating the effectiveness of p‐TIPS compared with standard care in reducing mortality and rebleeding in high‐risk patients with cirrhosis.
Wan Muhammad Izhar bin Wan Ismail +15 more
wiley +1 more source
Gastro-esophageal reflux in children [PDF]
, 2017 Gastro-esophageal reflux (GER) is common in infants and children and has a varied clinical presentation: from infants with innocent regurgitation to infants and children with severe esophageal and extra-esophageal complications that define pathological ...
Pesce M. +3 more
core +3 more sources
The use of vasoconstrictors in patients with liver cirrhosis: how, when, why
Clinical Management Issues, 2012 Portal hypertension (PH) is a severe complication of liver cirrhosis. Patients with PH run the risk of developing gastro-esophageal varices and massive gastrointestinal bleeding, ascites, hepatorenal syndrome, and hepatic encephalopathy.
Claudio Puoti
doaj +1 more source
United European Gastroenterology Journal, Volume 13, Issue 10, Page 2057-2065, December 2025.ABSTRACT Background Post‐endoscopy gastric cancer (PEGC) is a gastric cancer (GC) diagnosed within 3 years after an esophago‐gastro‐duodenoscopy (EGD) negative for cancer. Post‐endoscopy gastric cancer has a prevalence of 9%–11% in the western population and is potentially reducible through adequate surveillance and high‐quality endoscopy.
Ricard Prat +31 more
wiley +1 more source
Клінічна хірургія, 2018 Objective. Determination of efficacy of miniinvasive surgical treatment of portal hypertension (PG) in patients, suffering hepatic cirrhosis (HC) in immediate and late postoperative periods. Маterials and methods.
О. F. Dzygal, І. М. Deykalo
doaj +1 more source
United European Gastroenterology Journal, Volume 13, Issue 10, Page 1955-1963, December 2025.ABSTRACT Background and Aims The European Reference Network on Hepatological Diseases (ERN RARE‐LIVER) is a Europe‐wide network for centers of excellence in the management of rare liver diseases. We aimed to evaluate the current diagnostic and therapeutic trends of primary biliary cholangitis (PBC).
A. Gerussi +23 more
wiley +1 more source
JGH Open, Volume 9, Issue 10, October 2025.ABSTRACT Direct‐acting antivirals (DAAs) have dramatically improved sustained virological response (SVR) rates in patients with hepatitis C virus (HCV) infection. However, the risk of hepatocellular carcinoma (HCC) remains even after achieving SVR. We previously reported that alpha‐fetoprotein (AFP) levels at the end of treatment (EOT) were associated ...
Akifumi Kuwano +6 more
wiley +1 more source